Reviva Pharmaceuticals (NASDAQ:RVPH – Get Free Report)‘s stock had its “buy” rating reiterated by research analysts at HC Wainwright in a report released on Monday, Benzinga reports. They currently have a $20.00 price objective on the stock. HC Wainwright also issued estimates for Reviva Pharmaceuticals’ Q1 2025 earnings at ($0.33) EPS, Q2 2025 earnings at […]
Reviva Pharmaceuticals (NASDAQ:RVPH – Free Report) had its price target boosted by HC Wainwright from $10.00 to $20.00 in a research note released on Tuesday, Benzinga reports. HC Wainwright currently has a buy rating on the stock. HC Wainwright also issued estimates for Reviva Pharmaceuticals’ Q4 2023 earnings at ($0.30) EPS, Q1 2024 earnings at […]
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW – Get Free Report) was the target of a significant growth in short interest during the month of September. As of September 15th, there was short interest totalling 56,200 shares, a growth of 34.4% from the August 31st total of 41,800 shares. Based on an average trading volume of 27,300 […]
Reviva Pharmaceuticals Holdings, Inc. (NASDAQ:RVPHW – Get Free Report) saw a significant growth in short interest in the month of September. As of September 15th, there was short interest totalling 56,200 shares, a growth of 34.4% from the August 31st total of 41,800 shares. Based on an average daily volume of 27,300 shares, the days-to-cover […]
HC Wainwright restated their buy rating on shares of Reviva Pharmaceuticals (NASDAQ:RVPH – Free Report) in a research report sent to investors on Wednesday morning, Benzinga reports. The firm currently has a $10.00 target price on the stock. RVPH has been the subject of several other reports. Benchmark started coverage on shares of Reviva Pharmaceuticals […]